Jeunesse Stem Cells and Luminesce Dr. Newman
http://www.RedefiningYouthGlobal.com Jeunesse StemCells and Luminesce Dr. Newman Luminesce defies aging from the inside out. This powerful video explains how. Jeunesse StemCells and ...
By: Dotti Berry
See the original post here:
Jeunesse Stem Cells and Luminesce Dr. Newman - Video
What Are Stem Cells? How Do Stem Cells Work?
Dr Newman explains what stem cells are how they work. This is the cutting edge technology in skincare. You no longer have to go under the knife or get injections to have beautiful skin. http://ga...
By: Sandy Garland
Originally posted here:
What Are Stem Cells? How Do Stem Cells Work? - Video
What is regenerative medicine
Siddharth Tambar MD discusses regenerative medicine treatments for arthritis and tendinitis, including prp and stem cells.
By: Chicago Arthritis
Read more:
What is regenerative medicine - Video
Developing stem cell therapy as an alternative to corneal transplants.
Professor Julie Daniels talks about her tissue engineering research.
By: Fight for Sight
Read the original here:
Developing stem cell therapy as an alternative to corneal transplants. - Video
Stem Cell Therapy For Multiple Sclerosis
Back for round 2. After treatment in 2014 Beverly had improvement in her energy level, balance, walking and had colors come into her vision for the first time in 10 years. Beverly went blind...
By: Stem Cell Patient
Read more here:
Stem Cell Therapy For Multiple Sclerosis - Video
Irvine, Calif., March 26, 2015 -- Leslie Thompson of the Sue & Bill Gross Stem Cell Research Center at UC Irvine has been awarded $5 million by the California Institute for Regenerative Medicine to continue her CIRM-funded effort to develop stem cell treatments for Huntington's disease.
The grant supports her next step: identifying and testing stem cell-based treatments for HD, an inherited, incurable and fatal neurodegenerative disorder. In this project, Thompson and her colleagues will establish an HD therapy employing human embryonic stem cells that can be evaluated in clinical trials.
Over the past seven years, Thompson, a UCI professor of psychiatry & human behavior and neurobiology & behavior, and her team have used CIRM funding to produce stem cell lines "reprogrammed" from the skin cells of individuals carrying the Huntington's genetic mutation in order to study the disease. In addition, they conducted basic and early-stage transitional studies to develop a stem cell-based technique to treat areas of the brain susceptible to HD.
"These stem cells offer a possible long-term treatment approach that could relieve the tremendous suffering experienced by HD patients and their families," said Thompson, who's also affiliated with UCI's Institute for Memory Impairments and Neurological Disorders (UCI MIND). "We appreciate CIRM and the millions of people in the state of California for generously supporting breakthrough stem cell research."
With this award, CIRM has granted Thompson $10.3 million for her HD work. Overall, UCI has received $105 million from the state-funded agency.
Thompson said that her group has identified a highly promising neural stem cell line that shows disease-modifying activity in HD mice. These neural stem cells were grown from human embryonic stem cells at UC Davis. The researchers also will conduct essential preclinical efficacy and safety studies in HD mice with these cells.
Over the span of the 2-year grant, Thompson said, the goal is to finalize work that will lead to a pre-investigational-new-drug meeting with the Food & Drug Administration and a path forward for clinical trials with the neural stem cells.
"This investment will let us further test the early promise shown by these projects," said Jonathan Thomas, chair of the CIRM governing board. "Preclinical work is vital in examining the feasibility, potential effectiveness and safety of a therapy before we try it on people. These projects all showed compelling evidence that they could be tremendously beneficial to patients. We want to help them build on that earlier research and move the projects to the next level."
HD is a devastating degenerative brain disorder with no disease-modifying treatment or cure. Current approaches only address certain symptoms of HD and do not change its course.
###
Continued here:
UCI team gets $5 million to create stem cell treatment for Huntington's disease
Bobby Chia (Foto by Allan Defensor)
THERE is a lot of hype going on in some circles about stem cell therapy: Is it a cure-all? Is it the elusive fountain of youth?
Wikipedia definesstem cell therapy as the use of stem cells to treat or prevent a disease or condition.The process involves the administration of live whole cells or maturation of a specific cell population in a patient for the treatment of the disease as has been done in bone marrow transplants.
Bobby Chia, a Thai national who was in Cebu for a brief visit, said that stem cell therapy has been done in Villa Medica, Germany, since the 1960s. He learned about it 10 years ago when his mother had cancer and he looked around for the best medical care for her and found it in Villa Medica. It made her so much better (she can even play tennis now) that four years ago, Chia bought the clinic being run by Dr. Geoffrey Huertgen, a third generation doctor of that clinic.
The stem cell can be taken from the patient himself, but Chia says this stem source is naturally as old as the patient himself. Villa Medica chooses to use stem cells from fetuses of sheep (he said that stem cells from any mammal would be the same, but sheep stem cells are the ones more readily available). The process for Villa Medica, says Chia, involves the designing of a cocktail of stem cells to address whatever needs correction. If the eyes are not good, we choose the eyes. If the ears are not good, we choose the ears. If the heart is not good, we choose the heart. The procedure has been known to treat diseases and ailments like Parkinsons, diabetes, hypertension, migraine, allergies etc.
It (stem cell therapy) does not make you 18 years old all over again but it energizes you; from not being able to walk to walking again. It gives you a better quality of life. It is not a quick cure, but for a lot of people it is. We offer a choice for people who have no hope, Chia shares. But my main target is people who are not sick, Chia states, referring to athletes, models, professionals who want to have a better quality of life.
Chia says there are four doctors in Villa Medica. Since the cell therapy is patient-specific, the patient needs to stay four days and four nights at the clinic: for a detox program, for physical check-up, for interview, for determining the cocktail of stem cells to be used and how. The result, Chia says,is not immediate. It may take six weeks or even longer for the stem cells to do their work.
Chia says he has had about 150 patients coming from Cebu. Leaf through the pages of the local papers, one of them might just be there!
Published in the Sun.Star Cebu newspaper on March 27, 2015.
Originally posted here:
On stem cell therapy, benefits
Celprogen Released Stem Cell Active Ingredients for the Cosmetic Industry Tested and Validated in Cosmetic Products for a Decade
The present invention relates to culturing stem cells in animal free conditions has been developed and optimized by Celprogen utilizing single use bioreactor technology. The cosmetic industry has benefited from this technology for their regenerative skin care product lines. The topical application of these skin care products utilizing Celprogens Stem Cell Derived Conditioned Media have been in the market for 10 plus years.
About Celprogen Inc. Celprogen Inc. is a global Stem Cell Research & Therapeutics company which is developing a proprietary portfolio of unique therapeutics products and life science research tools that includes genetic engineering technologies, stem cell technologies for regenerative medicine, as well as bio-engineering products for tissue & organ transplants. Headquartered in Torrance, California, Celprogen is committed to the research, development, and manufacture of quality Stem Cell, Cancer Stem Cell and Primary Cell Culture products to serve our global community. Additional information about Celprogen is available at http://www.celprogen.com.
For additional information on the product line contact: Jay Sharma Phone: 310 542 8822 info@celprogen.com http://www.celprogen.com
Read the original here:
Celprogen Released Stem Cell Active Ingredients for the Cosmetic Industry Tested and Validated in Cosmetic Products ...
How Stem Cells work at Nova Cells Institute, 562-916-3410
How stem cells work and are successful for treatments at Nova Cells Institute, NCIM makes a difference because we care - successes with dementia, spina bifida, cancer and more - visit http://www.no...
By: NCIM
Follow this link:
How Stem Cells work at Nova Cells Institute, 562-916-3410 - Video
How stem cells can fix a broken heart with just one jab: 15-minute procedure could transform
How stem cells can fix a broken heart with just one jab: 15-minute procedure could transform lives of patients with heart failure A pioneering treatment that uses stem cells to repair...
By: MediaMac
The rest is here:
How stem cells can fix a broken heart with just one jab: 15-minute procedure could transform - Video
JEUNESSE LUMINESCE cellular rejuvenation Serum Anti Aging Skin Care Stem Cell Technology
Based on the latest available technology, LUMINESCE cellular rejuvenation serum makes a powerful debut as the first anti-aging product that supports your body #39;s natural ability to restore...
By: Dennis Eng
Read the original post:
JEUNESSE LUMINESCE cellular rejuvenation Serum Anti Aging Skin Care Stem Cell Technology - Video
Stem Cell Therapy - Lilli Donovan
Created using PowToon -- Free sign up at http://www.powtoon.com/join -- Create animated videos and animated presentations for free. PowToon is a free tool that allows you to develop cool...
By: Lilli Donovan
See more here:
Stem Cell Therapy - Lilli Donovan - Video
Boston, MA (PRWEB) March 24, 2015
The opening keynote address presented by Asymmetrex, LLC to an assembled audience of about 100 international experts in stem cell science, medicine, and engineering challenged attendees to consider whether the past 10 years of rapid growth of heterologous stem cell transplantation trials was the best path to achieving effective regenerative medicines. Among the participants there were a number of clinical and industry experts who pursued heterologous stem cell treatments. To a large extent, heterologous stem cell transplantation treatments involve evaluating bone marrow-derived or fat-derived cells as possible therapies for illnesses and disorders in other organs and tissues. Sherley suggested that such clinical trials were motivated primarily by the easier access and greater availability of these types of cell preparations instead of good biological rationale. This intentional provocation got the conference off to energetic discussion that continued throughout the day.
As the co-chair of the conferences first-days focus on stem cell medical engineering, Sherley shared with attendees Asymmetrexs essential technological basis, which is the asymmetric self-renewal of adult tissue stem cells. Sherley related how all Asymmetrexs innovative technologies for advancing stem cell medicine were derivative of the companys superior research position on asymmetric self-renewal, which is the unique property of adult tissue stem cells that defines their function in the body. Adult tissue stem cells multiply to continuously replenish expired mature tissue cells without losing their own stem cell identity. Because embryonic stem cells and induced pluripotent stem cells do not have asymmetric self-renewal, they are incapable of providing lasting cellular therapies.
Sherley described how each of Asymmetrexs patented technologies for stem cell medicine was based on asymmetric self-renewal. Asymmetrex holds patents for the only method described for routine production of natural human tissue stem cells that retain their normal function. The company also holds patents for biomarkers that can be used to count tissue stem cells for the first time. The companys most recently developed technology was invented with computer-simulation leader, AlphaSTAR Corporation. In partnership, the two companies created a first-of-its-kind method for monitoring adult tissue stem cell number and function for any human tissue that can be cultured. This advance is the basis for the two companies AlphaSTEM technology for detecting adult tissue stem cell-toxic drug candidates before conventional preclinical testing in animals or clinical trials. Asymmetrex and AlphaSTAR plan to market the new technology to pharmaceutical companies. The implementation of AlphaSTEM technology would accelerate drug development and reduce adverse drug events for volunteers and patients. At full capacity use, AlphaSTEM could reduce U.S. drug development costs by $4-5 billion each year.
About Asymmetrex (http://asymmetrex.com/)
Asymmetrex, LLC is a Massachusetts life sciences company with a focus on developing technologies to advance stem cell medicine. Asymmetrexs founder and director, James L. Sherley, M.D., Ph.D. is an internationally recognized expert on the unique properties of adult tissue stem cells. The companys patent portfolio contains biotechnologies that solve the two main technical problems production and quantification that have stood in the way of successful commercialization of human adult tissue stem cells for regenerative medicine and drug development. In addition, the portfolio includes novel technologies for isolating cancer stem cells and producing induced pluripotent stem cells for disease research purposes. Currently, Asymmetrexs focus is employing its technological advantages to develop facile methods for monitoring adult stem cell number and function in clinically important human tissues.
Read the original here:
Asymmetrex Opens Up 5th World Congress on Cell and Stem Cell Research in Chicago with a Focus on Its New Technologies ...
Contact Information
Available for logged-in reporters only
Newswise March 24, 2015, NATIONAL HARBOR, Md. - Mesenchymal stem cell (MSC) transplantation reduced opioid tolerance and opioid-induced hyperalgesia caused by daily morphine injections in rats, according to new research. The results could herald stem cell transplantation as an innovative, safe, efficacious and cost-effective therapy to treat pain and opioid tolerance, said researchers, who presented results in a Plenary Research Highlight session at the 31st Annual Meeting of the American Academy of Pain Medicine.
Not only was opioid tolerance prevented when the rats were transplanted with MSC before repeated morphine injections, but tolerance was reversed when the rats were treated after opioid tolerance had developed, results demonstrated.
MSCs have a remarkable anti-inflammatory effect and a powerful anti-tolerance effect, said the studys principal investigator, Jianguo Cheng, M.D., Ph.D., who led the research team from the Cleveland Clinic, in Ohio. Although clinical trials are still three to five years away, he said, eventually, The results may apply to millions of patients with a wide range of pain states, including cancer pain and other intractable chronic pain that requires long-term opioid therapy.
Furthermore, Cheng characterized the procedure as practical, in light of readily available sources of stem cells, reliable stem cell technology, the simplicity of transplantation procedures and the fact that clinical trials are already underway involving autoimmune and other diseases.
The Institute of Medicine report on pain in America documented millions who suffer with chronic pain (Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. National Academies Press [US]; 2011). Opioid therapy is a cornerstone component of pain management for many people with severe, ongoing pain; however, side effects such as tolerance and the risks posed by abuse, addiction and drug overdose limit its utility. Tolerance, a physiologic process in which the patients body adjusts to a dose and no longer achieves pain relief, is a common limitation with opioid therapy. The higher doses that result can limit effectiveness and compromise safety.
Glial cells are of growing interest in pain research and have been implicated in the development of tolerance. Glial cell activity also produces pain through the release of products that excite the nervous system, playing an important role in the spinal cord during nerve injury. Furthermore, the opioids used to treat pain, also can induce glial activity, causing pain relief to drop and unwanted opioid effects, including tolerance, dependence, reward and decreased breathing, to grow. A focus of research, then, is to separate the desired effect of pain relief from the unwanted opioid effects (Watkins et al, Trends in Pharmacological Sciences 2009;30(11): 581-91).
Interest in transplant of stem cells is another maturing research avenue (Hsu et al, Cell Transplant 2007;16(2):133-50). MSCs can differentiate into a variety of cell types and have been investigated for potential repair of damaged neural cells and for calming inflammation in the immune system to promote recovery after traumatic brain injury (Zhang et al, J Neuroinflammation 2013;10(1):106).
Following this line of research, the study investigators wondered whether they could create an anti-tolerance therapy by transplanting MSCs into the intrathecal space surrounding the spinal cord. With approval by the Cleveland Clinic Institutional Animal Care and Use Committee and funding through the Department of Defenses Congressionally Directed Medical Research Programs, they compared the withdrawal thresholds of the hind paws in response to painful mechanical and thermal stimuli in two groups of rats that received daily morphine injections. The first group was treated with MSC transplantation and the control group with phosphate-buffered saline (PBS).
See more here:
Cleveland Clinic Researchers First to Demonstrate Significant Blocking of Opioid Tolerance With Mesenchymal Stem Cell ...
VANCOUVER -- University of B.C. scientists appear to be one step closer to reversing diabetes using stem cell therapy.
The latest study, published last week in the journal Stem Cell Reports, found that Type 2 diabetes can be eliminated in mice using a combination of conventional diabetes drugs and specially cultured stem cells. Similar methods have already been used to reverse Type 1 diabetes, which usually begins in childhood.
The team simulated Type 2 diabetes in mice by feeding them a high-fat, high-calorie diet for several weeks. In humans, Type 2 usually begins in adulthood and can be a result of obesity, poor diet and lack of exercise.
Like diabetic humans, the diabetic mice treated only with drugs experienced spikes in their blood sugar levels after eating sugary meals.
But the mice that were surgically implanted with pancreatic-like cells grown from human stem cells didnt have those drastic swings and were able to regulate their blood sugar like healthy animals.
Being able to reduce spikes in blood sugar levels is important because evidence suggests its those spikes that do a lot of the damage increasing risks for blindness, heart attack, and kidney failure, said Timothy Kieffer, a professor in UBCs department of cellular and physiological sciences.
So far, the researchers have followed the mice for up to seven months, and theyve remained healthy.
When we removed the transplanted devices and analyzed the cells within, they still appear very healthy so we believe they will function much longer. Ultimately the duration of cell function will need to be assessed in humans, Kieffer said in an email.
Human trials are already underway for stem cell therapy on Type 1 diabetes; the first patient was implanted with cells in October.
The treatment also had a surprising side-effect: weight loss. The mice all returned to the same, healthy weight as the animals in the control group.
Follow this link:
Stem cell therapy could reverse Type 2 diabetes, UBC study finds
LPGN Laminine introduction
Laminine, a natural supplement, is believed to be the only other known source of FGF in adults. Research credits FGF with essentially reprogramming adult stem cells and amino acids in the body...
By: Inga Atoui
Visit link:
LPGN Laminine introduction - Video
HDLUMINESCE Serum - JEUNESSE Anti-Aging Skin Care Stem Cell Technology by Dr Newman
http://bit.ly/18IYR8y - Based on the latest available technology, LUMINESCE cellular rejuvenation serum makes a powerful debut as the first anti-aging product that supports your body #39;s...
By: ANTI-AGING SELECTIONS
View original post here:
HDLUMINESCE Serum - JEUNESSE Anti-Aging Skin Care Stem Cell Technology by Dr Newman - Video
Lisa Ann Walter with MDSUN Signature Collagen Lift
MDSUN Collagen Lift: Experiencing a revolutionary breakthrough with our triple DNA (Plant Stem Cells, Synthetic Animal Stem Cells Synthetic Human Stem Cells) and peptides infused Collagen...
By: MDSUN Skin Care, Inc.
Read the original post:
Lisa Ann Walter with MDSUN Signature Collagen Lift - Video
HDJEUNESSE FINITIAn Anti-Aging Nutrients w TA65 Protect Cells, DNA Lengthen Telomeres
http://bit.ly/18IYR8y - JEUNESSE FINITI naturally enhances the enzyme (telomerase) needed to lengthen our short telomeres. natural nutrients that protect our cells, DNA, stem cells, and...
By: ANTI-AGING SELECTIONS
See the original post:
HDJEUNESSE FINITIAn Anti-Aging Nutrients w TA65 Protect Cells, DNA & Lengthen Telomeres - Video
WSCS 2014: DATA ANALYSIS NEEDS IN REGENERATIVE MEDICINE (SUPPORTED BY BIOSCIENCE TECHNOLOGY)
Moderator - Tim Studt, Advantage Media Speakers - Michele Reilly, Turing, Inc. Michael Vassar, MetaMed James M. Watt, PhD, Eagle Medical Services, LLC.
By: worldstemcell
Read the original post:
WSCS 2014: DATA ANALYSIS NEEDS IN REGENERATIVE MEDICINE (SUPPORTED BY BIOSCIENCE TECHNOLOGY) - Video